default author photo

Jung-Yun Lee

Yonsei University - Department of Obstetrics and Gynecology

SCHOLARLY PAPERS

6

DOWNLOADS

325

TOTAL CITATIONS

0

Scholarly Papers (6)

1.

Utility of the CA125 KELIM in for Predicting the Benefit of from HIPECin Patients with Advanced Ovarian Cancer: Pooled Analysis of Individual Data from KGOG3042 and KOV-HIPEC-01

Number of pages: 30 Posted: 01 Jun 2025
Korea University, Ajou University School of Medicine, Chinese Academy of Medical Sciences - Center for Gynecologic CancerNational Cancer Center, Korea - Center for Gynecologic Cancer, Chinese Academy of Medical Sciences - Center for Gynecologic Cancer, Chinese Academy of Medical Sciences - National Cancer Center, Yonsei University - Department of Obstetrics and Gynecology, Seoul National University - Seoul National University Bundang Hospital, Korea University - Korea University Anam Hospital, CHA University, Ewha Womans University, Seoul National University - College of Medicine, Université de Lyon - Université Claude Bernard Lyon 1 and - Faculty of Medicine Lyon-Sud
Downloads 87 (771,553)

Abstract:

Loading...

Modeled CA-125 elimination rate constant K (KELIM), Hyperthermic intraperitoneal chemotherapy (HIPEC), Ovarian cancer, Chemotherapy response, Predictive biomarker

2.

Efficacy of Immune-Checkpoint Inhibitors Combined with Cytotoxic Chemotherapy in Advanced or Recurrent Endometrial Cancer: A Systematic Review and Meta-Analysis

Number of pages: 18 Posted: 18 Jan 2024
Chinese Academy of Medical Sciences - National Cancer Center, CHA University, Chinese Academy of Medical Sciences - National Cancer Center, Kosin University, Seoul National University, National University Health System (NUHS) - National University Cancer Institute, Yonsei University - Department of Obstetrics and Gynecology, Chinese Academy of Medical Sciences - National Cancer Center, Chinese Academy of Medical Sciences - Center for Gynecologic CancerNational Cancer Center, Korea - Center for Gynecologic Cancer and Imperial College London - Department of Surgery and Cancer
Downloads 79 (823,616)

Abstract:

Loading...

Endometrial cancer, immune checkpoint inhibitors, mismatch repair, prognosis, survival

3.

Efficacy and Safety of Triplet Maintenance Therapy (Olaparib, Pembrolizumab, And Bevacizumab) in BRCA Non-Mutated Patients with Platinum-Sensitive Recurrent Ovarian Cancer: A Multi-Centre, Single-Arm Phase II Study (OPEB-01/APGOT-OV4/MK 3475-B32)

Number of pages: 28 Posted: 21 Oct 2022
Yonsei University - Department of Obstetrics and Gynecology, Sungkyunkwan University - Biomedical Statistics Center, Seoul National University - Department of Obstetrics and Gynecology, Sungkyunkwan University - Department of Obstetrics and Gynecology, Yonsei University - Department of Obstetrics and Gynecology, Seoul National University - Department of Obstetrics and Gynecology, Sungkyunkwan University - Samsung Medical Center, Chinese Academy of Medical Sciences - Center for Gynecologic CancerNational Cancer Center, Korea - Center for Gynecologic Cancer, National University Health System (NUHS) - National University Cancer Institute, National University Health System (NUHS) - National University Cancer Institute and Yonsei University - Department of Obstetrics and Gynecology
Downloads 77 (830,555)

Abstract:

Loading...

Ovarian Neoplasms, Platinum-resistant, BRCA wild type, PARP inhibitor, Immunotherapy

4.

Efficacy of Chemotherapy Following Prior Parp-Inhibitor Treatment in Patients with Ovarian Cancer

Number of pages: 26 Posted: 19 Jun 2024
affiliation not provided to SSRN, Yonsei University - Department of Obstetrics and Gynecology, Yonsei University - College of Medicine, affiliation not provided to SSRN, Yonsei University - Gangnam Severance Hospital, Yonsei University - Department of Obstetrics and Gynecology, Yonsei University - College of Medicine, Yonsei University, Seoul National University - Department of Obstetrics and Gynecology, Seoul National University - Seoul National University Hospital and Sungkyunkwan University - Samsung Medical Center
Downloads 31 (1,318,317)

Abstract:

Loading...

Ovarian cancer, PARP inhibitor, Prognosis, recurrence, Survival

5.

Guideline-Practice Gap in Molecular Subtyping and Lynch Syndrome Screening for Endometrial Cancer

Number of pages: 33 Posted: 06 Nov 2025
Yonsei University - Department of Obstetrics and Gynecology, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Yonsei University - Department of Obstetrics and Gynecology, Yonsei University - College of Medicine, affiliation not provided to SSRN, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 30 (1,345,526)

Abstract:

Loading...

endometrial cancer, Lynch syndrome, microsatellite instability, mismatch repair

6.

Stereotactic Ablative Body Radiotherapy May Enhance Outcomes in Oligometastatic Uterine Cervical Cancer

Number of pages: 20 Posted: 17 Apr 2025
Yonsei University - Department of Radiation Oncology, Yonsei University, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Yonsei University - Department of Obstetrics and Gynecology, Yonsei University - Gangnam Severance Hospital, Yonsei University - Department of Obstetrics and Gynecology, Yonsei University - College of Medicine and Yonsei University
Downloads 21 (1,448,301)

Abstract:

Loading...

Uterine Cervical Neoplasms, Oligometastasis, Stereotactic Ablative Body Radiotherapy, Programmed Cell Death Ligand 1